Pharmacoproteomic Effects of Isoniazid, Ethambutol, and N-Geranyl-N′-(2-adamantyl)ethane-1,2-diamine (SQ109) on Mycobacterium tuberculosis H37Rv

Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence

Stewart T. Cole, Roland Brosch, Julian Parkhill et al. · Nature · 1998 · 7.9K citations · Full text

Life Sciences, Microbiology, Molecular Biology +12

American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: Treatment of Tuberculosis

American Journal of Respiratory and Critical Care Medicine · 2003 · 2K citations

Public Health, Health Policy, Pharmacotherapy +17

Regulation of the <i>Mycobacterium tuberculosis</i> hypoxic response gene encoding α-crystallin

David R. Sherman, Martin I. Voskuil, Dirk Schnappinger et al. · Proceedings of the National Academy of Sciences · 2001 · 742 citations · Full text

Life Sciences, Microbiology, Molecular Biology +17

The primary mechanism of attenuation of bacillus Calmette–Guérin is a loss of secreted lytic function required for invasion of lung interstitial tissue

Tsungda Hsu, Suzie Hingley‐Wilson, Bing Chen et al. · Proceedings of the National Academy of Sciences · 2003 · 739 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +12

Modification of the NADH of the Isoniazid Target (InhA) from <i>Mycobacterium tuberculosis</i>

Denise A. Rozwarski, Gregory A. Grant, D. H. R. BARTON et al. · Science · 1998 · 680 citations

Medicine, Biochemistry, Pharmacology +16